Big4Bio Podcast
As economic pressures weigh on the ability of life science companies to raise capital, there is pressure to do more with less. With investors growing more risk averse, companies are taking steps to cut expenses without jeopardizing the pace at which they can advance their work to the next financeable milestone.
Big4Bio spoke with Danforth co-founder Gregg Beloff about the current financial environment for biotech companies, how they can extend their cash runways, and what steps they can take to better position themselves to fund their growth.